“Magic” mushrooms and their active ingredient, psilocybin, may treat symptoms of depression, British scientists suggest. The research was posted in the Proceedings of the National Academy of Sciences journal after one of the first studies done since the 1960’s.
“One of the parts of the brain that is markedly switched off [with psilocybin] is the anterior cingulate cortex, which is particularly overactive in people with depression,” said David Nutt, professor of neuropsychopharmacology at Imperial College, London. Some researchers “put electrodes in that part of the brain to switch it off. It would be a lot simpler and safer to use psilocybin instead of electrodes.”
This study was very basic, but I think it merits further research. Psilocybin is labeled as a Schedule I Drug in the United States meaning that it has highly addictive qualities, no accepted medical value, and no safe method of conducting scientific research.
With the medical properties of marijuana becoming apparent to the public, it may facilitate open dialogue on these other potentially helpful and healing substances.